ADMA250117P21000
- 3.91
- 0.000.00%
ADMA Biologics Newsroom
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
4 Biotech Stocks Most Wall Street Analysts Are Bullish About
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $28
Express News | ADMA Biologics Inc : Mizuho Raises Target Price to $28 From $24
ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip?
Looking Into ADMA Biologics's Recent Short Interest
Can Adma Biologics (ADMA) Climb 25.5% to Reach the Level Wall Street Analysts Expect?
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating
10 Health Care Stocks With Whale Alerts In Today's Session
ADMA Biologics (NASDAQ:ADMA) Seems To Use Debt Quite Sensibly
Adma Biologics (ADMA) Is on the Move, Here's Why the Trend Could Be Sustainable
Insider Sale: CFO and Treasurer of $ADMA (ADMA) Sells 15,000 Shares
ADMA Biologics Announces Board Resignations and Appointments
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $24
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
NASDAQ New 52-Week Highs And Lows
Earnings Beat: Here's What ADMA Biologics, Inc. (NASDAQ:ADMA) Analysts Are Forecasting For Next Year
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $24